Barstad Melanie W. has filed 90 Form 4 transactions, all in Cintas Corporation (CTAS), with a clear directional bias toward selling. Over the reporting period, she recorded zero open-market purchases and $1,855,277.48 in open-market sales, while acquiring $1,204,787.02 in shares through compensation-related events such as grants and option exercises. The most recent open-market sale occurred on July 16, 2026, when she disposed of CTAS shares valued at $1,855,277.48, the largest single transaction in the series. That same day, she exercised options worth $285,850.80 and had $286,036.64 in shares withheld to cover tax obligations, a routine mechanical transaction.
The pattern is dominated by recurring equity awards rather than discretionary buying. Between July 2025 and July 2026, Barstad received a steady stream of grants (coded "A") in amounts ranging from roughly $1,400 to $31,900, with several awards clustered around the $31,874 mark. These include grants on July 28, 2026 ($31,873.97), April 14, 2026 ($31,874.29), January 20, 2026 ($31,874.10), and October 28, 2025 ($31,874.94). Smaller quarterly grants of roughly $1,800 to $2,100 also appeared in August, October, December, February, March, and May, reflecting a routine compensation schedule rather than market-timing signals.
The July 16, 2026 sale stands out as the only recent open-market disposition, and it aligns with the option exercise that occurred the same day. The absence of any open-market purchases, combined with the recurring grant-and-sell cadence, suggests a portfolio management approach rather than a directional bet on CTAS. The data shows a steady accumulation of shares through compensation, punctuated by a single large liquidation event, with no evidence of recent buying activity.
AI-assisted summary